Dr Mark Kellett, Consultant Neurologist

Dr Mark Kellett

Consultant Neurologist

Book online
|

Dr Mark Kellett MB BS, B.Med.Sci(Hons), MD FRCP

Consultant Neurologist

MB BS, B.Med.Sci(Hons), MD FRCP

Dr Mark Kellett

Consultant Neurologist MB BS, B.Med.Sci(Hons), MD FRCP

Book online
|
MB BS, B.Med.Sci(Hons), MD FRCP
HCA-Healthcare-UK

Areas of expertise

  • General neurology
  • Parkinson’s disease
  • Dystonia, epilepsy and tremor
  • Headache and migraine
  • Multiple sclerosis
HCA-Healthcare-UK

Recommendations for Dr Kellett

These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.

Recommended by:

  • byDr Andrew Robinson, Consultant Gastroenterologist

    Dr Mark Kellett is a kind, caring and competent neurologist.

  • by Dr Neil Davidson, Consultant Cardiologist

    Dr Mark Kellett is a highly-respected neurologist with excellent communication skills.

  • byDr Andrew Robinson, Consultant Gastroenterologist

    Dr Mark Kellett is a kind, caring and competent neurologist.

  • by Dr Neil Davidson, Consultant Cardiologist

    Dr Mark Kellett is a highly-respected neurologist with excellent communication skills.

  • Address

    • HCA UK at The Wilmslow Hospital

      52-54 Alderley Road Wilmslow, London, SK9 1NY

    About Dr Mark Kellett

    GMC number: 3489354

    Year qualified: 1991

    Place of primary qualification: University of Newcastle upon Tyne

    Dr Mark Kellett is a highly experienced Consultant Neurologist based at Salford Royal NHS Foundation Trust, home to the Manchester Centre for Clinical Neurosciences, one of the UK's largest neuroscience units. He serves as the Chairman of this prestigious centre. Dr Kellett's specialist areas of interest include movement disorders, particularly Parkinson's disease and dystonia. He is also proficient in managing headaches and migraines and chronic migraine management.

    In addition to his role at Salford Royal, Dr Kellett joined the Neurofibromatosis Type 2 Service at St Mary's Hospital in Manchester. This service is one of four specialist nationally commissioned centres in England, where he serves as a Consultant Neurologist.

    Dr Kellett obtained his medical qualification from Newcastle University in 1991. He completed his specialist training at the Walton Centre for Neurology and Neurosurgery in Liverpool in 2004. During his time there, he also achieved a Doctor of Medicine degree focused on the genetic epidemiology of Parkinson's disease. He was appointed a Member of the Royal College of Physicians (MRCP) of Edinburgh in 1994 and became a Fellow of the Royal College of Physicians (FRCP) of London in 2004.

    Dr Kellett is a representative on the national specialist commissioning clinical reference group for neurological disorders on behalf of the Greater Manchester, Lancashire, and South Cumbria Senate. He is also the Clinical Lead of the Strategic Clinical Network for Neurological Disorders.

    Dr Kellett's extensive expertise and leadership roles make him a key figure in the field of neurology, particularly in the management of movement disorders and chronic migraines.

    Areas of expertise

    • General / Emergency Neurology
    • Headache and migraine
    • Investigation of Weakness or sensory disturbance
    • Epilepsy and Blackouts
    • Multiple sclerosis including prescribing of Fampiridine
    • Movement disorders
    • Parkinson’s disease
    • Dystonia
    • Treatment for various types of dystonia, tics and hemifacial spasm
    • Treatment for chronic migraine

    Professional memberships

    Royal College of Physicians
    Association of British Neurologists (ABN)
    International Parkinson and Movement Disorder Society
    American Academy of Neurology

    Articles by Dr Mark Kellett

    Familial unilateral vestibular schwannoma is rarely caused by inherited variants in the nf 2 gene: familial unilateral vestibular schwannoma

    Genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy.

    Clinical features and natural history of neuroferritinopathy caused by the ftl1 460insa mutation

    High-grade glioma is not a feature of neurofibromatosis type 2 in the unirradiated patient

    Compliance to new guidelines for cerebral venous thrombosis across greater manchester

    Dystonia associated with idiopathic slow orthostatic tremor

    Spinal ependymomas in nf2: a surgical disease?

    Quality of life after epilepsy surgery